Hyperglycemia

A recently described type of neonatal diabetes mellitus is caused by mutations in the YIPF5 gene and is combined with manifestations from the central nervous system, including developmental delay, epilepsy, and microcephaly. The molecular …

Diabetes is a chronic systemic metabolic disorder that emerges when there is inadequate insulin secretion or when the cells are unable to effectively utilize insulin for the metabolism of sugar [ 1 ]. The global prevalence of diabetes mellitus (DM) …

Diabetes mellitus (DM) is a metabolic disorder characterized by elevated plasma glucose that impacts multiple organ systems. It encompasses various subtypes such as type 1 DM (T1DM), type 2 DM (T2DM), maturity-onset diabetes of the young (MODY) …

Diabetic neuropathy is a complication of diabetes mellitus that results from the metabolic and vascular disturbances associated with diabetes. It has been shown that up to 50–66% of all diabetic patients develop some sort of diabetic neuropathy …

Type 2 diabetes is a chronic condition that affects insulin function and production, leading to high blood glucose levels; symptoms include tiredness and excessive thirst. It is also associated with an increased risk of developing other problems …

Nutritional intake could influence the blood glucose profile during early life of preterm infants. We investigated the impact of macronutrient intake on glycemic homeostasis using continuous glucose monitoring (CGM). We analyzed macronutrient …

Breast cancer is the most commonly diagnosed malignancy among women in the United States, excluding nonmelanoma of the skin, and the second leading cause of cancer death in women, after lung cancer [ 1 ]. Hormone receptor positive (HR +), human …

In critically ill patients, hyperglycaemia is common and is associated with poor outcomes [ 1 , 2 ]. However, the results of the landmark Leuven study [ 3 ], which ushered in ‘tight glycaemic control’, were not reproduced in subsequent multicentre …